A Study to Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment
Clinical trial NCT03097016 · COMPLETED
Trial details
- NCT number
- NCT03097016
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-30
- Primary completion
- 2017-12-23
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.